How has been the historical performance of HCP Plastene?

Answer:The historical performance of HCP Plastene shows significant fluctuations in key financial metrics over the years.

Breakdown:
HCP Plastene's net sales experienced a notable increase from Mar'24 at 294.56 Cr to Mar'25 at 463.44 Cr, following a dip in Mar'23 at 351.56 Cr and a dramatic decline from Mar'22's 11,219.74 Cr. Total operating income mirrored this trend, rising to 463.44 Cr in Mar'25 from 294.56 Cr in Mar'24. The raw material cost also increased significantly, reaching 350.29 Cr in Mar'25 from 212.20 Cr in Mar'24, while total expenditure rose to 428.20 Cr in Mar'25. Operating profit (PBDIT) improved to 39.92 Cr in Mar'25, up from 19.23 Cr in Mar'24, indicating a recovery from the previous years' losses. Profit before tax turned positive at 18.01 Cr in Mar'25, compared to a mere 0.20 Cr in Mar'24, and profit after tax rose to 13.36 Cr from 0.31 Cr. The consolidated net profit for Mar'25 was 9.63 Cr, a recovery from losses in the previous years. Earnings per share (EPS) also improved to 9.03 in Mar'25 from -1.12 in Mar'24. However, the company faced challenges with total liabilities increasing to 206.70 Cr in Mar'24 from 175.25 Cr in Mar'23, and total debt rising to 157.90 Cr. Cash flow from operating activities remained negative at -18.00 Cr in Mar'24, though cash flow from financing activities was positive at 23.00 Cr. Overall, HCP Plastene's financial performance indicates a recovery trend in sales and profitability, despite ongoing challenges with liabilities and cash flow.